Investment
Features
FeesSafety
Academy
More
Pluang+

GRAIL stock jumps 30% on positive FDA briefing for Galleri cancer test ahead of AdCom meeting

Analyst Insights
21 Sep 2026
Seeking Alpha
View Source
Bullish
GRAIL stock jumps 30% on positive FDA briefing for Galleri cancer test ahead of AdCom meeting

GRAIL's stock surged over 30% after FDA briefing notes highlighted optimism for its Galleri cancer test, which shows high specificity (99.6%) and positive predictive value up to 77%. While sensitivity remains moderate, the test reduces late-stage cancer diagnoses. The analyst rates GRAIL as a Buy, anticipating FDA approval could boost adoption, though risks remain around revenue, reimbursement, and competition. Share price volatility is expected as valuation and insurer coverage remain uncertain.

GRAIL's stock surge follows an FDA briefing that highlights its Galleri cancer test's high specificity and predictive value. For readers following the health sector, here is Pluang's market snapshot as of Sep 22, 2026 01:32 WIB: out of 95 priced US health stocks, 62 rose and 32 fell. Among notable movers, Aurora Cannabis Inc (ACB) rose 4.01% to USD 4.03 with 100% buy orders and a typical hold time of 26 days, Agilent Technologies Inc (A) increased 3.96% to USD 162.66 with a 38-day hold, and Recursion Pharmaceuticals Inc (RXRX) gained 3.92% to USD 3.98 with 59% buy orders and a 22-day hold.

More News

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing is experiencing ongoing production challenges with its 737 MAX aircraft, causing delays and a recent 3.7% stock drop. Jefferies lowered its price target to $265, still implying a 32% upside from current prices, reflecting cautious optimism. Ba...

Analyst Insights
Neutral
1 hour ago
Diamond prices plunge 30-40% as lab-grown stones flood market, while Bitcoin value surges.

Diamond prices plunge 30-40% as lab-grown stones flood market, while Bitcoin value surges.

Natural diamond prices have dropped 30-40% from their 2021 highs due to oversupply, weaker demand, and a surge in cheaper lab-grown diamonds, whose prices have fallen over 75% since 2022. This has pressured mid-tier natural diamonds, leaving only the...

Market News
Bearish
4 hours ago
AllianceBernstein Global High Income Fund updates portfolio with $973M in assets and 1,186 holdings as of August 2026

AllianceBernstein Global High Income Fund updates portfolio with $973M in assets and 1,186 holdings as of August 2026

AllianceBernstein Global High Income Fund, Inc. released its portfolio update as of August 31, 2026, reporting total net assets of $973.28 million and 1,186 holdings. The fund's portfolio is diversified across various sectors including non-investment...

Market News
Neutral
4 hours ago
AllianceBernstein updates portfolio with $333.69M in municipal bonds, focusing on airports and schools.

AllianceBernstein updates portfolio with $333.69M in municipal bonds, focusing on airports and schools.

AllianceBernstein National Municipal Income Fund released its August 31, 2026 portfolio update, showing $333.69 million in net assets invested primarily in municipal bonds. The fund's top holdings include bonds from airports, school districts, and tr...

Market News
Neutral
4 hours ago
AllianceBernstein funds declare October income distributions for shareholders.

AllianceBernstein funds declare October income distributions for shareholders.

AllianceBernstein Closed-End Funds announced income distributions for October 2026. The Global High Income Fund will pay $0.0655 per share, and the National Municipal Income Fund will pay $0.05018 per share. Both distributions have an ex-date and rec...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App